EV/EBITDA:
-7.33+0.39(+5.05%)Summary
- As of today (September 11, 2025), CRSP EV/EBITDA is -7.33, with a rise of +0.39 (+5.05%) during the most recent trading session on September 10, 2025.
- Over the past year, CRSP EV/EBITDA has dropped by -0.59 (-8.75%).
- CRSP EV/EBITDA is now -100.34% below its all-time high of 2142.90.
Performance
CRSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRSP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.0% | -5.1% | -3.5% |
| 1 m1 month | +9.2% | -9.3% | -6.5% |
| 3 m3 months | -71.3% | +64.5% | +24.8% |
| 6 m6 months | -67.7% | +63.9% | +22.3% |
| ytdytd | -93.4% | +89.0% | +31.6% |
| 1 y1 year | -8.8% | +52.5% | +14.0% |
| 5 y5 years | -100.5% | -32.1% | -35.2% |
CRSP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.33 | at high | -8.97 | +18.3% |
| 3 m | 3-month | -4.23 | -73.3% | -10.32 | +29.0% |
| 6 m | 6-month | -2.33 | -214.6% | -10.32 | +29.0% |
| 1 y | 1-year | -2.33 | -214.6% | -10.32 | +29.0% |
| 3 y | 3-year | -2.13 | -244.1% | -33.74 | +78.3% |
| 5 y | 5-year | 1854.46 | -100.4% | -48.40 | +84.9% |
| alltime | all time | 2142.90 | -100.3% | -759.60 | +99.0% |
CRSP EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.33(+93.4%) |
| 2024 | -3.79(-80.9%) |
| 2023 | -19.83(+693.2%) |
| 2022 | -2.50(-126.6%) |
| 2021 | 9.40(-133.5%) |
| Date | Value |
|---|---|
| 2020 | -28.06(-151.6%) |
| 2019 | 54.42(-925.8%) |
| 2018 | -6.59(-43.1%) |
| 2017 | -11.59(+59.0%) |
| 2016 | -7.29 |
FAQ
- What is CRISPR Therapeutics AG EV/EBITDA?
- What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
- What is CRSP EV/EBITDA year-to-date change?
- What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
What is CRISPR Therapeutics AG EV/EBITDA?
The current EV/EBITDA of CRSP is -7.33
What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high EV/EBITDA is 2142.90
What is CRSP EV/EBITDA year-to-date change?
CRISPR Therapeutics AG EV/EBITDA has changed by -3.54 (-93.40%) since the beginning of the year
What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
Over the past year, CRSP EV/EBITDA has changed by -0.59 (-8.75%)